Atypical antipsychotic drugs in the treatment of delusional parasitosis

International Journal of Psychiatry in Medicine

Volumn 37, Issue 1, 2007, Pages 29-37

  Mercan, Sibel ^a,c   Altunay, Ilknur Kivanc ^a   Taskintuna, Nilgun ^b   Ogutcen, Ozgur ^a   Kayaoǧlu, Semra ^a  

^a Sisli Etfal Research and Teaching Hospital   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Amisulpride; Delusional parasitosis; Olanzapine; Risperidone

Indexed keywords

AMISULPRIDE; AMITRIPTYLINE; ATYPICAL ANTIPSYCHOTIC AGENT; BIPERIDEN; CHLORQUINALDOL; CYANOCOBALAMIN; DIFLUCORTOLONE VALERATE; FEXOFENADINE; FLUCONAZOLE; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; HYDROCHLOROTHIAZIDE PLUS IRBESARTAN; HYDROXYZINE; OLANZAPINE; PAROXETINE; RISPERIDONE; BENZODIAZEPINE DERIVATIVE; DRUG DERIVATIVE; NEUROLEPTIC AGENT; SULPIRIDE; SULTOPRIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DELUSION; DELUSIONAL PARASITOSIS; DEPRESSION; DRUG DOSE INCREASE; DRUG EFFECT; FEMALE; HEART INFARCTION; HUMAN; MALE; PANIC; PARASITOSIS; PRURITUS; SOMATOFORM DISORDER; SYMPTOMATOLOGY; TINEA PEDIS; ADOLESCENT; CASE REPORT; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; FOLLOW UP; INJECTION; MIDDLE AGED; PARANOID SCHIZOPHRENIA; PARESTHESIA; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PARASITIC DISEASES; PARESTHESIA; PATIENT COMPLIANCE; RISPERIDONE; SCHIZOPHRENIA, PARANOID; SOMATOFORM DISORDERS; SULPIRIDE; TREATMENT OUTCOME;

EID: 34547573007     PISSN: 00912174     EISSN: 15413527     Source Type: Journal    
DOI: 10.2190/M8M5-H1G2-1257-2017     Document Type: Article

References (17)

1. Rasanen P, Erkonen K, Isaksson U, Koho P, Varis R, Timonen M, Leinonnen E, Isohannni M, Alanko A. Delusional parasitosis in the elderly: a review and report of six cases from northern Finland. International Psychogeriatrics 1997;9(4):459-464.
2. Trabert W. Shared psychotic disorder in delusional parasitosis. Psychopathology 1999;32(1):30-34.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington DC, American Psychiatric Association, 1994.
4. Le L, Gonski PN. Delusional parasitosis mimicking cutaneous infestation in elderly patients. The Medical Journal of Australia 2003;179(4):209-210.
5. Johnson GC, Anton RF. Delusions of parasitosis: differential diagnosis and treatment. The Southern Medical Journal 1985;78(8):914-918.
6. Gould WM, Gragg TM. Delusions of parasitosis. An approach to the problem. Archives of Dermatology 1976;112(12):1745-1748.
7. Aw DC, Thong JY, Chan HL. Delusional parasitosis: case series of 8 patients and review of the literature. Annals of the Academy of Medicine, Singapore 2004;33(1):89-94.
8. Driscoll MS, Rothe MJ, Grant-Kels JM, Hale MS. Delusional parasitosis: a dermatologic, psychiatric, and pharmacologic approach. Journal of the American Academy of Dermatology 1993;29(6):1023-1033.
9. Bhatia MS, Jagawat T, Choudhary S. Delusional parasitosis: a clinical profile. International Journal of Psychiatry in Medicine 2000;30(1):83-91.
10. Gallucci G, Beard G. Risperidone and the treatment of delusions of parasitosis in an elderly patient. Psychosomatics 1995;36(6):578-580.
11. De Leon OA, Furmaga KM, Canterbury AL, Bailey LG. Risperidone in the treatment of delusions of infestation. International Journal of Psychiatry in Medicine 1997;27(4):403-409.
12. Elmer KB, George RM, Peterson K. Therapeutic update: use of risperidone for the treatment of monosymptomatic hypochondriacal psychosis. Journal of the American Academy of Dermatology 2000;43(4):683-686.
13. Mercan S, Ogutcen O, Altunay IK, Karamustafalioglu O. Folie famille ve deluzyonel parazitoz: olgu sunumu ve literaturun gozden gecirilmesi. Klinik Psikofarmakoloji Bulteni 2005;15(2):71-78.
14. Slaughter JR, Zanol K, Rezvani H, Flax J. Psychogenic parasitosis. A case series and literature review. Psychosomatics 1998;39(6):491-500.
15. Committee on safety of medicines annual report for 2004. Medicines Act 1968 Advisory Bodies Annual Reports.
16. Zareba W, Lin DA. Antipsychotic drugs and QT interval prolongation. The Psychiatric Quarterly 2003;74(3):291-306.
17. Stollberger C, Huber JO, Finsterer J. Antipsychotic drugs and QT prolongation. International Clinical Psychopharmacology 2005;20(5):243-251.